<?xml version="1.0" encoding="UTF-8"?>
<ref id="B146-biomedicines-08-00109">
 <label>146.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nyon</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Tseng</surname>
    <given-names>C.K.</given-names>
   </name>
   <name>
    <surname>Seid</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Pollet</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Naceanceno</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Agrawal</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Algaissi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>B.H.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen</article-title>
  <source>Vaccine</source>
  <year>2018</year>
  <volume>36</volume>
  <fpage>1853</fpage>
  <lpage>1862</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.02.065</pub-id>
  <?supplied-pmid 29496347?>
  <pub-id pub-id-type="pmid">29496347</pub-id>
 </element-citation>
</ref>
